Results from a large cohort study indicate that a proportion of stage pT1b-pT2a melanoma patients could potentially avoid entinel lymph node biopsy (SLNB).
Archive | Of Interest
Study Suggests Which Melanoma Patients May Avoid Sentinel Node Biopsy
Posted in Melanoma News, Health Professionals, Of Interest
Source of DNA mutations in melanoma
The mutations that give rise to melanoma result from a chemical conversion in DNA fueled by sunlight — not just a DNA copying error as previously believed, reports a study by Van Andel Institute scientists published today in Science Advances.
Posted in Melanoma News, Health Professionals, Of Interest
Melanoma incidence, prevalence have increased in US in recent decades
While melanoma incidence and prevalence in the U.S. increased between 1990 and 2019, mortality rates remained stable over that time, according to findings from a mathematical model.
Posted in Melanoma News, Health Professionals, Of Interest
Nanotechnology may help improve treatment for colorectal cancer and melanoma
University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors.
Posted in Melanoma News, Health Professionals, Of Interest
